Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Dustin

Showing results (331-340 of 343) with videos related to

Pageof 35
Sort By:
Cell|April 30, 2025
Selective requirement of glycosphingolipid synthesis for natural killer and cytotoxic T cellsTasha A Morrison, Jaelyn Vigee, Kevin A Tovar, et al.
Nature Communications|June 17, 2022
T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesiclesPablo F Céspedes, Ashwin Jainarayanan, Lola Fernández-Messina, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Human CD8-iTreg are potent GVHD suppressors and tumoricidal effectors by release of Granzyme-K <sup>+</sup> Supramolecular Attack ParticlesJemma H Larson, Ewoud B Compeer, Phillip R Dougherty, et al.
The Journal of Clinical Investigation|September 30, 2025
Acetyl-CoA carboxylase 1 inhibition increases Treg metabolism and graft-versus-host disease treatment efficacy via mitochondrial fusionCameron McDonald-Hyman, Ethan G Aguilar, Ewoud B Compeer, et al.
The Journal of Experimental Medicine|November 14, 2023
A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammationVictor G Lui, Manfred Hoenig, Berenice Cabrera-Martinez, et al.
The Journal of Clinical Investigation|August 15, 2018
The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host diseaseCameron McDonald-Hyman, James T Muller, Michael Loschi, et al.
Nature Communications|April 24, 2024
Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cellsMike B Barnkob, Yale S Michaels, Violaine André, et al.
Nature Communications|April 12, 2024
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cellsMike B Barnkob, Yale S Michaels, Violaine André, et al.
Nature Communications|February 6, 2025
Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanismsShivan Sivakumar, Ashwin Jainarayanan, Edward Arbe-Barnes, et al.
Nature Immunology|April 1, 2024
Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicityMegat H B A Hamid, Pablo F Cespedes, Chen Jin, et al.
Pageof 35

Showing results (331-340 of 343) with videos related to

Sort By:
Pageof 35
Cell|April 30, 2025
Selective requirement of glycosphingolipid synthesis for natural killer and cytotoxic T cellsTasha A Morrison, Jaelyn Vigee, Kevin A Tovar, et al.
Nature Communications|June 17, 2022
T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesiclesPablo F Céspedes, Ashwin Jainarayanan, Lola Fernández-Messina, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Human CD8-iTreg are potent GVHD suppressors and tumoricidal effectors by release of Granzyme-K <sup>+</sup> Supramolecular Attack ParticlesJemma H Larson, Ewoud B Compeer, Phillip R Dougherty, et al.
The Journal of Clinical Investigation|September 30, 2025
Acetyl-CoA carboxylase 1 inhibition increases Treg metabolism and graft-versus-host disease treatment efficacy via mitochondrial fusionCameron McDonald-Hyman, Ethan G Aguilar, Ewoud B Compeer, et al.
The Journal of Experimental Medicine|November 14, 2023
A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammationVictor G Lui, Manfred Hoenig, Berenice Cabrera-Martinez, et al.
The Journal of Clinical Investigation|August 15, 2018
The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host diseaseCameron McDonald-Hyman, James T Muller, Michael Loschi, et al.
Nature Communications|April 24, 2024
Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cellsMike B Barnkob, Yale S Michaels, Violaine André, et al.
Nature Communications|April 12, 2024
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cellsMike B Barnkob, Yale S Michaels, Violaine André, et al.
Nature Communications|February 6, 2025
Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanismsShivan Sivakumar, Ashwin Jainarayanan, Edward Arbe-Barnes, et al.
Nature Immunology|April 1, 2024
Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicityMegat H B A Hamid, Pablo F Cespedes, Chen Jin, et al.
Pageof 35